亚太区股市全面随外围偏软 惟新西兰逆市屡创纪录高
美股昨晚全面回软结束四连涨,虽然美国9月NFIB小型企业信心及10月IBD经济乐观指数分别创七个月及八个月高远胜预期,但新冠肺炎疫苗研发有不利消息,加上美国众议院议长佩洛西拒绝接纳白宫提出1.8万亿美元支援经济方案新建议,影响投资气氛,逾三分二蓝筹回吐,尤其是Walgreens、因有接种疫苗後患上不明疾病暂停测试旗下新冠肺炎疫苗的强生、苹果、波音及Travelers跌逾2%-3%,摩通上季意外多赚4%,但净利息收入跌近10%,股价跌1.6%,花旗上季少赚34%仍胜预期,但股价跌4.8%,其他主要银行股也跌逾1.5%-3.5%,但重组传媒及娱乐业务的迪士尼逆升逾3%,沃尔玛也升1.4%,道指由曾吐233点,收窄至仅吐157点或近0.6%收28,679,标普也吐0.6%,微软逆市续升近0.7%,支持纳指仅反覆吐0.1%。此外,欧洲主要股市跌0.5%-1.1%。
美股期货全面反覆回稳,纳指期货回升0.3%报12,127,道指及标普期货分别报28,590及3,508,反覆微升5点及3点。不过,亚太区股市普遍受压。美元兑日圆於亚洲再度回落至105.3,日经继昨天反覆微弹0.2%後,今早跌0.3%报23,543。
台湾加权指数及韩股继昨天微吐结束八连涨後,现造12,914及2,386,续吐近0.3%及0.7%。澳洲200继昨天受惠银行股推动续升1%後,今早微吐0.1%报6,190。
新加坡第三季GDP初值季调後环比恢复增长7.9%(前值萎缩扩至13.2%)。但星股扭两连升,报2,560,跌0.3%。马股未能延续昨天反弹势,报1,521,跌0.2%。
港股继昨天台风休市後,今早复市延续之前急弹逾2%强势,高开159点或0.6%报24,808欠承接,在三年来首次不在中国美元债承销商之列汇控(00005.HK)股价挫逾3.5%主导,掉头低见24,569,现造24,595,倒跌54点或0.2%。
内地9月以美元计价出口额按年升幅加快至9.9%略逊预期,但进口额按年急弹13.2%远胜预期,期内贸易顺差环比意外收窄至370亿美元,远低市场预期环比顺差扩至600亿美元。深成及沪指继昨天反覆续升近0.7%及靠稳後,今早低开0.2%及0.1%分别报3,353及13,781,现造3,346及13,741,回吐0.4%。
不过,新西兰连续第五天创纪录高,今早高低见12,505/12,431,现造12,493,续升0.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.